← All funding rounds

Philochem raises €315.0M round

10 June 2025· Otelfingen, Switzerland· health, oncology, drug_discovery, biotech, dna_encoded_libraries, chemical_biology, b2b

Upfront payment as part of a global licensing agreement where RayzeBio obtained exclusive worldwide rights to develop, manufacture, and commercialize OncoACP3, a therapeutic and diagnostic agent targeting prostate cancer.

Investors

LeadRayzeBio

About Philochem

Headquarters

Otelfingen, Switzerland

Founded

2006

Team Size

21–50

Sectors

healthoncologydrug_discoverybiotechdna_encoded_librarieschemical_biologyb2b

http://www.philochem.ch/en/

Source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFTbqrqV9rQo1EOvu8cXDTbYVGGNGuGNjom0IraLGeD1--gapQ8Cp-ancuuOPq4IIhjd43eFmlpQmlW72zkzaFzOvap6dhCrAsrRmh1fPPbu21jVFBNhCSKjLD5PZIEHyz6DfrNsIY1pkRkuZERHp_JwAJeZo_cF1MeP8R8J9ehGf11CNSuZTMlo32ROOrcP7cM0LRbB-tpHdSRVuUqkpsjCKnkYDPwS6mtjLg_R5UFKbZUO8KFp6Jd8A